Telehealth company offers compounded semaglutide and tirzepatide with upfront pricing, a choice of trusted pharmacies, board-certified providers, and quarterly Starter Packs for first-time patients.

Ondra Health has launched its telehealth platform to expand access to GLP-1 weight management across the U.S., built around the idea that getting started should not be the hardest part of losing weight.

For many patients, the obstacle has never been the medication — it has been everything around it. Confusing pricing. Unclear sourcing. Platforms that feel more like subscriptions than healthcare. Ondra was built to remove that friction.

The platform offers compounded semaglutide from $149/month and compounded tirzepatide from $219/month, with the price held flat across every dose. First-time GLP-1 patients can also begin with a quarterly Starter Pack — a three-month plan starting from $249 for semaglutide or $399 for tirzepatide.

Ondra also gives patients a choice of pharmacy. Rather than routing every order through one partner, Ondra works with a network of trusted, licensed U.S. compounding pharmacies operating in compliance with applicable state and federal compounding regulations, and offers eligible patients a selection of licensed pharmacy partners during checkout based on availability and state eligibility — with pricing shown clearly upfront before any commitment.

“People don’t need another health subscription. They need a clear answer and a place to start,” said spokesperson for Ondra Health. “We built Ondra so the price you see is the price you pay, and the choice stays with the patient.”

Getting started takes minutes. Patients complete a short online intake, a board-certified provider reviews their case, and approved medication ships straight to their door with ongoing support throughout treatment. Patients also have access to help with questions, dose adjustments, and refills through clear, direct communication rather than slow ticket queues.

Ondra Health is LegitScript-verified and HIPAA-compliant. Compounded medications are prepared by licensed pharmacies under Section 503A or 503B in compliance with FDA guidance and USP sterile compounding standards. They are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products.

Ondra Health is now accepting patients nationwide. To learn more, visit https://ondra.health.

About Ondra Health

Ondra Health is an independently-owned, Los Angeles–based telehealth company offering personalized GLP-1 treatment plans through board-certified providers and trusted U.S. compounding pharmacies — built around transparent pricing, patient choice, and clear communication.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260527391223/en/